'''AH-7921''' is an [[opioid]] [[analgesic]] drug selective for the [[mu opioid receptor|µ-opioid receptor]], having around 80% the potency of [[morphine]] when administered orally.<ref>{{cite journal | first1=R. T. | last1=Brittain | title=Proceedings: Anti-nociceptive effects in N-substituted cyclohexylmethylbenzamides | last2=Kellett | first2=D. N. | last3=Neat | first3=M. L. | last4=Stables | first4=R. | journal=British Journal of Pharmacology | date=September 1973 | volume=49 | issue=1 | pages=158P–159P | doi=10.1111/j.1476-5381.1973.tb08279.x | pmc=1776456 | pmid=4207044}}</ref><ref>{{cite journal | first1=A. G. | last1=Hayes | title=Determination of receptors that mediate opiate side effects in the mouse | last2=Tyers | first2=M. B. | journal=British Journal of Pharmacology | date=July 1983 | volume=79 | issue=3 | pages=731–736 | doi=10.1111/j.1476-5381.1983.tb10011.x | pmc=2044905 | pmid=6317119}}</ref><ref>{{cite journal | url=http://pubs.acs.org/doi/abs/10.1021/jm00257a012 | title=1-(3,4-Dichlorobenzamidomethyl)cyclohexyldimethylamine and related compounds as potential analgesics |author1=N. J. Harper |author2=G. B. A. Veitch |author3=D. G. Wibberley | journal=Journal of Medicinal Chemistry | date=November 1974 | volume=17 | issue=11 | pages=1188–1193 | doi=10.1021/jm00257a012 | pmid=4416926}}</ref> It was discovered in the 1970s<ref name='US Patent 3975443'>{{ cite patent | country = US | number = 3975443 | status = patent | inventor = Harper, N.; Veitch, G. | title = 1-(3,4-DICHLOROBENZAMIDOMETHYL)-CYCLOHEXYLDIMETHYLAMINE | gdate = 1976-08-17 | assign1 = Allen & Hanburys }}</ref> by a team at [[Allen & Hanburys|Allen and Hanburys]].
